There is no other way to say it. This year has been a terrible one for cleantech firms hoping to access the public markets to fund commercialization. Investors seem to be allergic to the very idea of owning stock in a cleantech firm. Cleantech Chemistry thinks that one might still squeak through before the end of [...]
Tags
Comments
Log in to leave a comment

